Aytu Biopharma (AYTU) Net Margin Growth (3y) (2017 - 2025)
Aytu Biopharma (AYTU) Net Margin Growth (3y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 948.00 |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 83.00 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | -94.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -990.00 |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | -604.00 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1,312.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Aytu Biopharma | 24.60 Mn | -2.12 Mn | 7.60 Mn | -1,359.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -2,495.00 |
| Mar 31, 2025 | 22,051.00 |
| Dec 31, 2024 | 5,070.00 |
| Sep 30, 2024 | 12,949.00 |
| Jun 30, 2024 | 7,131.00 |
| Dec 31, 2023 | 5,841.00 |
| Sep 30, 2023 | 2,822.00 |
| Jun 30, 2023 | 4,101.00 |
| Mar 31, 2023 | 3,371.00 |
| Dec 31, 2022 | 14,505.00 |
| Sep 30, 2022 | 33,993.00 |
| Jun 30, 2022 | 29,230.00 |
| Mar 31, 2022 | -3,125.00 |
| Dec 31, 2021 | 21,069.00 |
| Sep 30, 2021 | 11,682.00 |
| Jun 30, 2021 | 41,484.00 |
| Dec 31, 2020 | 33,580.00 |
| Sep 30, 2020 | 39,038.00 |
| Jun 30, 2020 | 75,857.00 |
| Mar 31, 2020 | 48,754.00 |